MURINE CYTOMEGALOVIRUS-INFECTION IN THE SPLEEN AND ITS RELATIONSHIP TO IMMUNOSUPPRESSION

被引:32
作者
LOH, L [1 ]
HUDSON, JB [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC MED,DIV MED MICROBIOL,VANCOUVER V6T 1W5,BC,CANADA
关键词
D O I
10.1128/IAI.32.3.1067-1072.1981
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1067 / 1072
页数:6
相关论文
共 26 条
[1]   PROTECTIVE EFFECT OF EARLY SERUM FROM MICE AFTER CYTOMEGALOVIRUS-INFECTION [J].
ARAULLOCRUZ, TP ;
HO, M ;
ARMSTRONG, JA .
INFECTION AND IMMUNITY, 1978, 21 (03) :840-842
[2]   PROGRESSIVE INHIBITION OF T-CELL FUNCTION PRECEDING CLINICAL SIGNS OF CYTOMEGALOVIRUS-INFECTION IN MICE [J].
BOOSS, J ;
WHEELOCK, EF .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (03) :478-481
[3]  
BOOSS J, 1975, P SOC EXP BIOL MED, V149, P443
[4]   RESISTANCE TO MURINE CYTOMEGALOVIRUS LINKED TO MAJOR HISTOCOMPATIBILITY COMPLEX OF MOUSE [J].
CHALMER, JE ;
MACKENZIE, JS ;
STANLEY, NF .
JOURNAL OF GENERAL VIROLOGY, 1977, 37 (OCT) :107-114
[5]   PRIMARY CYTOMEGALOVIRUS AND OPPORTUNISTIC INFECTIONS - INCIDENCE IN RENAL-TRANSPLANT RECIPIENTS [J].
CHATTERJEE, SN ;
FIALA, M ;
WEINER, J ;
STEWART, JA ;
STACEY, B ;
WARNER, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (22) :2446-2449
[6]   SYNERGISTIC INFECTION WITH MURINE CYTOMEGALOVIRUS AND PSEUDOMONAS-AERUGINOSA IN MICE [J].
HAMILTON, JR ;
OVERALL, JC .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (06) :775-782
[7]   SYNERGISTIC EFFECT ON MORTALITY IN MICE WITH MURINE CYTOMEGALOVIRUS AND PSEUDOMONAS-AERUGINOSA, STAPHYLOCOCCUS-AUREUS, OR CANDIDA-ALBICANS INFECTIONS [J].
HAMILTON, JR ;
OVERALL, JC ;
GLASGOW, LA .
INFECTION AND IMMUNITY, 1976, 14 (04) :982-989
[8]   RAPID DIAGNOSIS OF TICK-BORNE ENCEPHALITIS BY MEANS OF ENZYME LINKED IMMUNOSORBENT ASSAY [J].
HOFMANN, H ;
FRISCHNIGGEMEYER, W ;
HEINZ, F .
JOURNAL OF GENERAL VIROLOGY, 1979, 42 (MAR) :505-511
[9]   CELL-MEDIATED-IMMUNITY TO MURINE CYTOMEGALOVIRUS [J].
HOWARD, RJ ;
MATTSSON, DM ;
SEIDEL, MV ;
BALFOUR, HH .
JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (05) :597-604
[10]  
HOWARD RJ, 1974, CLIN EXP IMMUNOL, V18, P109